Literature DB >> 26592708

Protective effects of chicken egg yolk antibody (IgY) against experimental Vibrio splendidus infection in the sea cucumber (Apostichopus japonicus).

Xiaoyu Li1, Kailin Jing2, Xitao Wang2, Yuan Li2, Meixia Zhang2, Zhen Li2, Le Xu2, Lili Wang1, Yongping Xu3.   

Abstract

Vibrio splendidus is one of the most harmful pathogens associated with skin ulceration syndrome in the sea cucumber (Apostichopus japonicus) due to its high virulence and frequency of appearance. The objective of this study was to determine the effectiveness of chicken egg yolk antibody (IgY) against V. splendidus infection in the sea cucumber. Whole V. splendidus cells were used as an immunogen to immunize 20 White Leghorn hens (25 weeks old). IgY was produced from egg yolks obtained from these immunized hens using water dilution, two-step salt precipitation and ultrafiltration. The purity of the IgY produced was approximately 83%. Enzyme-linked Immunosorbent Assay indicated a high specificity for IgY with a maximum antibody titer of 320,000. The growth of V. splendidus in liquid medium was significantly inhibited by IgY in a dose-dependent manner at concentrations ranging from 1 to 10 mg/mL. The protective effects of IgY were evaluated in sea cucumber by intraperitoneally injecting anti-V. splendidus IgY antibodies (10 mg/mL) or immersing the sea cucumber in aqueous IgY (1 g/L) after an intraperitoneal injection of V. splendidus. Intraperitoneal injection resulted in an 80% survival while immersion resulted in a 75% survival during the 11-day experimental period. The survival rates were significantly higher than the positive control and the non-specific IgY group (P < 0.05). As well, the bacterial burden in the respiratory tree, intestine and coelomic liquid was significantly (P < 0.05) lower in sea cucumber treated with specific IgY than those treated with non-specific IgY. The phagocytosis of coelomocytes for V. splendidus in the presence of specific IgY was significantly (P < 0.05) higher than that obtained with non-specific IgY or without IgY, suggesting that specific IgY enhanced phagocytic activity. The current work suggests that specific IgY has potential for protecting sea cucumbers against V. splendidus infection.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apostichopus japonicas; Egg yolk antibody (IgY); Sea cucumber; Skin ulceration syndrome; Vibrio splendidus

Mesh:

Substances:

Year:  2015        PMID: 26592708     DOI: 10.1016/j.fsi.2015.11.024

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  5 in total

1.  Reduction of aGVHD using chicken antibodies directed against intestinal pathogens in a murine model.

Authors:  Abdellatif Bouazzaoui; Elisabeth Huber; Alexander Dan; Faisal A Al-Allaf; Jochen Pfirstinger; Günter Sprotte; Josef Köstler; Andreas Hiergeist; Andre Gessner; Wolfgang Herr; Ernst Holler
Journal:  Blood       Date:  2016-12-23       Impact factor: 22.113

Review 2.  Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.

Authors:  Tao Hong; Rui Wang; Xiaoqi Wang; Shijie Yang; Weihao Wang; Qiangguo Gao; Xi Zhang
Journal:  Front Immunol       Date:  2021-03-16       Impact factor: 7.561

3.  Passive Immune-Protection of Litopenaeus vannamei against Vibrio harveyi and Vibrio parahaemolyticus Infections with Anti-Vibrio Egg Yolk (IgY)-Encapsulated Feed.

Authors:  Xiaojian Gao; Xiaojun Zhang; Li Lin; Dongrui Yao; Jingjing Sun; Xuedi Du; Xiumei Li; Yue Zhang
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

4.  Codon optimization, expression in Escherichia coli, and immunogenicity analysis of deformed wing virus (DWV) structural protein.

Authors:  Dongliang Fei; Yaxi Guo; Qiong Fan; Ming Li; Li Sun; Mingxiao Ma; Yijing Li
Journal:  PeerJ       Date:  2020-03-11       Impact factor: 2.984

Review 5.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.